Physician profile
Gary E Kolb
NPI 1851355846
$1,373.86
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,223 · 2020: $124 · 2021: $26.40.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $448.65 | 2019-2020 | |
| Glaxosmithkline, LLC. | $181.93 | 2019-2020 | |
| Novo Nordisk INC | $147.19 | 2019 | |
| Silk Road Medical, INC. | $110.67 | 2019 | |
| Scilex Pharmaceuticals INC. | $72.59 | 2019 | |
| Sunovion Pharmaceuticals INC. | $69.11 | 2019 | |
| Allergan, INC. | $61.26 | 2019 | |
| Merck Sharp & Dohme LLC | $59.39 | 2019-2020 | |
| Amarin Pharma, INC. | $52.98 | 2019-2020 | |
| Pfizer INC. | $26.79 | 2019 | |
| Abbvie INC. | $26.40 | 2021 | |
| Lilly USA, LLC | $23.76 | 2019 | |
| Astellas Pharma US INC | $23.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.97 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.83 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $13.75 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.40 | 2019 | |
| Medtronic Vascular, INC. | $12.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Kolb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.